ReviewMycotoxin research2026
Biological detoxification of Ochratoxin A: current status, mechanisms, and applications.
Review in Mycotoxin research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Ochratoxin A (OTA) is a chemically stable and ubiquitous mycotoxin that poses persistent threats to environmental safety and public health due to its potent nephrotoxicity and carcinogenicity. Given the limitations of conventional physical and chemical remediation, biological detoxification has emerged as a sustainable and high-efficiency alternative. This review systematically evaluates three core biological strategies: biological inhibition via nutrient competition and metabolic interference; biosorption through non-covalent binding by microbial cell wall components; and biodegradation, focusing on the enzymatic cleavage of the amide bond or lactone ring. We highlight recent breakthroughs in OTA- degrading enzymes, such as carboxypeptidases and amidohydrolases, emphasizing their catalytic pathways and potential for recombinant expression. Furthermore, the practical applications, industrial challenges, and safety considerations of these green technologies are discussed. This work provides a comprehensive theoretical framework for developing eco-friendly and targeted strategies to safeguard the global food chain and mitigate environmental mycotoxin contamination.
Indexed as
Identifiers
42862491What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.